NM_006906.2:c.1261G>A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_006906.2(PTPN5):c.1261G>A(p.Gly421Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G421D) has been classified as Likely benign.
Frequency
Consequence
NM_006906.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251368 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461658Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727140 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74458 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1261G>A (p.G421S) alteration is located in exon 12 (coding exon 11) of the PTPN5 gene. This alteration results from a G to A substitution at nucleotide position 1261, causing the glycine (G) at amino acid position 421 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at